This post is part of the MDS 2023 Countdown series.  Disclaimer. Current as of December 23, 2022

WHAT YOU CAN EXPECT TO SEE

We will see changes in Section N of the MDS 3.0 effective on October 1, 2023.  Section N0410 (Medications Received) has been eliminated and is being replaced with Section N0415 (High Risk Drug Classes: Use and Indication).

The updated version expands the medication list to include antiplatelets and hypoglycemics including insulin. Also, the new section adds a column titled “indication noted.”

What is Section N Asking?

Per the draft instructions, the MDS Coordinator will check the appropriate box

if the resident is taking any medications by pharmacological classification, not how the medication is used, during the last 7 days or since admission/entry or re-entry if less than 7 days.

If column 1 is checked, check if there is an indication noted for all medications in the drug class.

The added item set will require clinicians to verify if the resident is taking the high-risk medications and determine whether an indication of use is documented for all medications received in the drug classes.

Antiplatelets:

  • ASA
  • Pletal/Cilostrazol
  • Plavix/Clopidogrel
  • Aggrenox
  • Brillinta/Ticagrelor
  • Persantine/Dipyridamole
  • Ticlid/Ticagrelor

Hypoglycemics:

  • Insulin
  • Metformin/Glucophage
  • Amaryl/Glimepiride
  • Prandin/Repaglinade
  • Actos/Pioglitazone
  • Januvia/Sitaglptin
  • Jardiance/Empagliflozin
  • Trulicity/Dulglutide
  • Victoza/Liraglutadine
  • Glucotrol/Glipizide

Examples of Antiplatelet and Hypoglycemic medications. (Not an all-inclusive list)

What Do the Changes Mean?

What does the addition of Use and Indication mean?

These high-risk drug classes, identified by CMS, will require staff education to recognize side effects that could adversely impact the resident’s health, quality of life, and safety.

The interdisciplinary team (IDT) led by a nurse, medical director, and pharmacist will need to identify high-risk medications used in the facility. The team will need to ensure staff, residents and resident representatives, understand indications for use, and monitor for adverse effects.

Recommendations from MDS Consultants

The MDS Coordinator will need to work in collaboration with facility leadership and the IDT to establish a process of review and monitor high risk medication. This process should be tracked and monitored as part of the facility’s QAPI program.

A review of documentation to ensure there is an indication when a high-risk medication is in use and monitoring for efficacy and adverse effects is completed should be completed now. If a gap is noted, a plan for improvement will need to be put in place and monitored.

Do not wait! The time to prepare is now.

More Resources

Explore More Posts from MDS Consultants

Get ready for October 1

Transportation – New Item A1250

This post is part of the MDS 2023 Countdown series.  Disclaimer. Current as of October 1, 2023 What You Can Expect to See An additional item we will see in the upcoming MDS 3.0 v.1.18.11 in October 2023 is A1250 - Transportation. This is included in a new subset of...

New 3-day Lookbacks | Assessment Periods

This post is part of the MDS 2023 Countdown series.  Disclaimer. Current as of March 24, 2023 What You Can Expect to See New 3-day lookback/assessment periods are coming to the MDS world. There are different sections of the MDS that the Nurse Assessment Coordinators...

New Pain Interview in Section J

This post is part of the MDS 2023 Countdown series.  Disclaimer. Current as of February 22, 2023 What You Can Expect to See The most noticeable changes to Section J are evident in the pain interview, specifically questions J0510, J0520 and J0530. The RAI Manual has...

Section B – Hearing, Speech and Vision Changes

This post is part of the MDS 2023 Countdown series.  Disclaimer. Current as of October 1, 2023 What You Can Expect to See Section B on the MDS is a component of the Standardized Patient Assessment Data Elements (SPADEs), which is utilized across post-acute care...

Race and Ethnicity – Changes in Section A

This post is part of the MDS 2023 Countdown series.  Disclaimer. Current as of October 1, 2023 What You Can Expect to See Section A, Identification Information for Race/Ethnicity has expanded. One of the major changes is the deletion of section A1000 Race/Ethnicity....

Read more on Toolbox Essentials

Focused Infection Control Surveys and Directed Plan of Correction

It's a dreary Monday morning, and the state surveyors walk into your facility to conduct a Focused Infection Control survey. You and your team have been trying your hardest to comply with infection control procedures throughout the pandemic. At the end of the survey,...

New Advanced Beneficiary Notice

Is your facility using the proper ABN form? The Centers for Medicare & Medicaid Services (CMS) recently updated the Advanced Beneficiary Notice of Noncoverage (ABN), Form CMS-R-131. The new ABN will be mandatory for use on 1/1/2021, but the new form can be...

Covid-19 and Skilled Status

In late June, CMS addressed two issues and posted MDS 3.0 Final Item Sets (V1.17.2).  The two edits were changes to facilitate the calculation of Patient-Driven Payment Model payment codes on OBRA assessments for states that wish to have this calculation performed. ...

Mind Your PHQs

Some skilled nursing facilities (SNFs) are concerned about accurate payment when a resident unexpectedly discharges and the Brief Interview for Mental Status (BIMS) has not yet been completed.However, they should be just as concerned about the PHQ-9. The PHQ-9...

MDS in the Emergency Preparedness Plan

The COVID-19 pandemic has highlighted the need for skilled nursing facilities to have an effective Emergency Preparedness Plan - one that includes sheltering-in-place. The Centers for Medicare and Medicaid Final Rule requires that participating providers have an...

MORE from MDS Experts

Coding UTIs on the MDS 3.0

Urinary Tract Infections (UTIs) are a commonly miscoded data element on the MDS. Are you over coding UTIs? Are you not coding them at all? Should you? Shouldn’t you? The MDS has historically left data collectors asking themselves these questions. What happens if I do...

Achieving Accurate ADLs with the OSA

Section G of the MDS 3.0 was retired October 1, 2023, yet the MDS nurse may still need to use the knowledge of accurately coding ADLs with an assessment called the Optional State Assessment (OSA).  State-Optioned OSA Although the option to choose an OSA from the...

What Is an MDS Coordinator?

It’s a bit odd that when asked what you do for a living most MDS coordinators struggle to come up with an answer. Who struggles to explain what they do every day? The reality is that MDS Coordinators fully understand what this multifaceted job entails, but are at a...

MDS 2023 Countdown Wrap-Up

This post is part of the MDS 2023 Countdown series.  Disclaimer: Current as of May 13, 2023.   What You Can Expect to See CMS released the first MDS draft item set (v1.18.11) in September 2022, which generated many questions for the long-term care community. Both...

Rx Reconciliation – New SNF QRP and QMs

This post is part of the MDS 2023 Countdown series.  Disclaimer. Current as of October 1, 2023 What You Can Expect to See The reconciled medication list will have a new documentation requirement that will go into effect with the October 1, 2023 changes to the MDS...

Webinars & Training

Grow your knowledge with our MDS education

MDS Guides & Forms

Exclusive resources & tools we use every day

Ask an Expert Forum

Members can get 1:1 advice from our MDS experts

Let's Meet in Person

Get more info on our training & conference schedule

News for MDS Experts

Browse our blog & get news alerts on MDS changes

MDS Completion

Get your MDS' done ASAP with short-term, expert help

Remote Floater

Fill gaps on your team when & where you need

Case Mix Index

Improve your complex case mix calculations

MDS System Mgt

Best practices for MDS schedules & workflow

+ More Services

Get help on PDPM, ICD-10, quality, schizoph. audits ++